BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2511818)

  • 1. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT; Triplett DA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The laboratory diagnosis of lupus anticoagulants.
    Lazarchick J; Kizer J
    Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.
    Triplett DA
    J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative sensitivity of different tests in the detection of low titer lupus anticoagulants.
    Lesperance B; David M; Rauch J; Infante-Rivard C; Rivard GE
    Thromb Haemost; 1988 Oct; 60(2):217-9. PubMed ID: 3146139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM; Barr CF; Johansen LE; Tang DB
    Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'.
    Exner T; Papadopoulos G; Koutts J
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):259-66. PubMed ID: 2129412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.
    Thiagarajan P; Pengo V; Shapiro SS
    Blood; 1986 Oct; 68(4):869-74. PubMed ID: 3092888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for the lupus anticoagulant.
    Triplett DA
    Ric Clin Lab; 1989; 19(4):379-89. PubMed ID: 2517352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphipathic peptides can act as an anticoagulant by competing with phospholipid membranes for blood coagulation factors.
    Charbonneau S; Peng HT; Shek PN; Blostein MD
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1197-202. PubMed ID: 20005198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.